JAJustine M. Abais-Battad

Justine M. Abais-Battad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Justine M. Abais-Battad has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Protective effects of fermentable dietary fiber and propionate in Dahl salt-sensitive hypertension and renal damage

    by Samuel D. Walton, John Henry Dasinger, Emily C. Burns-Ray, Lily N. Hartenburg, Kaitlyn E. Baldwin, Jeffrey Lin, Mary Cherian-Shaw, Ramakumar Tummala, Bina Joe, David L. Mattson, et al.

    The dietary switch to inulin, a fermentable fiber, reduced salt-sensitive hypertension and kidney injury in male and female Dahl SS rats, and caused gut microbiota composition shifts and increases in SCFA production (propionate and butyrate). Direct administration of propionate ameliorated salt-sensitivity in males, which coincided with renal T regulatory cell expansion. These findings provide the mechanistic basis for leveraging the microbiota and its metabolites through dietary interventions as a therapeutic for hypertension and kidney disease.


  • Exacerbation of Dahl SS Hypertension and Renal Damage by NOX2 in CD4+ T Cells

    by Samuel D. Walton, Emily C. Burns-Ray, John Henry Dasinger, Sadaf Hasan, Kaitlyn E. Baldwin, Mary Cherian-Shaw, Justine M. Abais-Battad, David L. Mattson

    BACKGROUND: Infiltration of T cells into the kidney of Dahl salt-sensitive (SS) rats accompanies SS hypertension and renal damage. Genetic deletion of T cells on the SS background (SS CD247 −/ − ) attenuates hypertension and renal damage, and adoptive transfer of T cells restores the disease phenotype in an NOX2 (NADPH oxidase 2)–dependent manner. This study aimed to identify the specific T-cell subtype involved in the amplification of Dahl SS hypertension. METHODS: Adoptive transfer of purified CD (cluster of differentiation) 4+ or CD8+ T cells isolated from SS rats or from rats with a genetic deletion of a subunit of NOX2 was performed into the SS CD247−/− . A negative control group received PBS vehicle. After 3 weeks of a high-salt (4.0% NaCl) diet, rats receiving CD4+ T cells from the SS demonstrated amplified SS hypertension and albuminuria compared with all other groups, including the rats that received CD4+ T cells lacking functional NOX2. RESULTS: No differences were observed in rats receiving CD8+ T cells. Flow cytometric analysis documented equal reconstitution of CD3+ cells in the adoptive transfer rats. A gene expression analysis demonstrated upregulation of inflammatory genes in the CD4+ cells in the kidney of the SS rats compared with the T cells of rats lacking functional NOX2. Subsequent experiments documented a positive correlation between CD4+ T cells in diseased human kidneys and renal damage, providing a translational aspect to this study. CONCLUSIONS: In summary, these studies indicate that CD4+ T cells amplify SS hypertension and renal damage in the Dahl SS rats via an NOX2-dependent mechanism.


  • Open Access

    T cell knockout attenuates HFD-induced increases in blood pressure in female and male Dahl rats

    by Lindsey A. Ramirez, Elizabeth Snyder, Riyaz Mohamed, Justine M. Abais-Battad, Hannah R. Godley-Boswell, John Henry Dasinger, David L. Mattson, Mike W. Brands, Babak Baban, Ahmed Elmarakby, et al.

    Increased body weight is associated with a higher incidence of hypertension in humans. Pre-clinical evidence shows that a high-fat diet (HFD) promotes hypertension. While T cells have been implicated in hypertension, the contribution of T cells to HFD-induced increases in blood pressure (BP) remains unknown. We tested the hypothesis that T cells mediate HFD-induced increases in BP in female and male Dahl rats. Female and male wildtype (WT) Dahl rats were randomized to a normal-fat diet (0.16% kcal from fat) or HFD (59% kcal from fat) from 5 to 15 weeks of age. Aortic and renal T cells were measured by flow cytometry. Additional female and male WT and CD247 (CD3ζ-chain) knockout (KO) Dahl rats were placed on a HFD from 5 to 15 weeks of age. Body weight and fat and lean mass were measured throughout, and BP was measured by telemetry throughout the last five weeks of treatment. At 15 weeks of age, rats were euthanized, and adipose tissues were weighed. HFD increased pro-inflammatory T cells and decreased anti-inflammatory T regulatory cells in the aorta and kidney in both sexes, indicating an increase in the pro-inflammatory status. HFD increased BP comparably in females and males, and the change in BP in response to HFD was blunted in CD247 KO rats of both sexes. The lower BP in CD247 KO rats was independent of changes in body weight or total fat mass. Our findings suggest that T cells contribute to HFD-induced hypertension in both sexes independent of changes in adiposity.


  • Impact of Hematopoietic CD14 on Oxidative Stress during Salt-Sensitive Hypertension and Kidney Injury

    by Emily C. Burns-Ray, John Henry Dasinger, Mary Cherian-Shaw, Samuel D. Walton, Kaitlyn E. Baldwin, Ann B. Cormier, Sadaf Hasan, Daniel J. Fehrenbach, Justine M. Abais-Battad, David L. Mattson

    Key Points: Deletion of CD14 in Dahl salt-sensitive females increased NADPH oxidase 2 oxidative stress in macrophages, exacerbated hypertension, and worsened kidney injury. Double knockout of CD14 and functional NADPH oxidase 2 via Ncf2 deletion ameliorated the exacerbated salt-sensitive phenotype of female salt-sensitive CD14−/− . Immune-specific double knockout of CD14 and p67phox via bone marrow transfer markedly attenuated hypertension and kidney damage. Background: In high-salt diet-fed Dahl salt-sensitive rats, increased Cd14 expression by infiltrating macrophages accompanies hypertension and kidney damage. Interestingly, genetic deletion of Cd14 in the Dahl salt-sensitive rat model (SS CD14−/− ) conferred a significant exacerbation of salt-induced hypertension and associated kidney disease in females. We speculated that CD14 may function to modulate the production of reactive oxygen species in macrophages, since previous findings implicated hematopoietic NADPH oxidase 2 (NOX2)–derived superoxide in the pathogenesis of salt-sensitive hypertension. This study tested the hypothesis that the amplification of salt-sensitive hypertension and kidney damage in salt-sensitive females lacking CD14 is dependent on NOX2. Methods: A double knockout salt-sensitive rat was bred to lack both CD14 and the critical p67 phox subunit of NOX2 (SS CD14−/−p67phox−/− ). In vivo and ex vivo experiments explored the consequences of CD14 deletion in addition to nonfunctional NOX2 on salt-induced BP, kidney damage, and inflammation. Complementary experiments using diseased human kidneys correlated our findings to humans. Results: We found that SS CD14−/− peritoneal macrophages demonstrated increased NOX2 subunit mRNA and a greater capacity to produce NOX2-superoxide versus genetically intact Dahl salt-sensitive rats, whereas SS CD14−/−p67phox−/− macrophages did not produce superoxide. We also showed that SS CD14−/−p67phox−/− females had significantly attenuated salt-induced hypertension, kidney damage, and renal inflammation compared with SS CD14−/− , indicating that NOX2 mediates the exacerbation of disease in CD14 absence. A subsequent total body irradiation/bone marrow transfer approach using Dahl salt-sensitive female recipients and transfer of SS CD14−/−p67phox−/− bone marrow recapitulated these findings, demonstrating a clear interplay of CD14 and NOX2 specifically in immune cells. Finally, consistent with observations in the Dahl salt-sensitive rats, immunohistochemical observations in human tissue demonstrated a positive correlation between kidney damage, CD68 + macrophages, and CD14 in the kidney. Conclusions: We highlight a novel regulatory pathway whereby hematopoietic CD14 influences NOX2-derived oxidative stress and therefore modulates the progression of hypertension and kidney disease.


  • Open Access

    Revisiting sex as a biological variable in hypertension research

    by Michael J. Ryan, John S. Clemmer, Roy O. Mathew, Jessica L. Faulkner, Erin B. Taylor, Justine M. Abais-Battad, Fiona Hollis, Jennifer C. Sullivan

    Half of adults in the United States have hypertension as defined by clinical practice guidelines. Interestingly, women are generally more likely to be aware of their hypertension and have their blood pressure controlled with treatment compared with men, yet hypertension-related mortality is greater in women. This may reflect the fact that the female sex remains underrepresented in clinical and basic science studies investigating the effectiveness of therapies and the mechanisms controlling blood pressure. This Review provides an overview of the impact of the way hypertension research has explored sex as a biological variable (SABV). Emphasis is placed on epidemiological studies, hypertension clinical trials, the genetics of hypertension, sex differences in immunology and gut microbiota in hypertension, and the effect of sex on the central control of blood pressure. The goal is to offer historical perspective on SABV in hypertension, highlight recent studies that include SABV, and identify key gaps in SABV inclusion and questions that remain in the field. Through continued awareness campaigns and engagement/education at the level of funding agencies, individual investigators, and in the editorial peer review system, investigation of SABV in the field of hypertension research will ultimately lead to improved clinical outcomes.


  • Functional NADPH oxidase 2 in T cells amplifies salt-sensitive hypertension and associated renal damage

    by Samuel D. Walton, John Henry Dasinger, Emily C. Burns, Mary Cherian-Shaw, Justine M. Abais-Battad, David L. Mattson

    Our current work used the adoptive transfer of T cells that lack functional NADPH oxidase 2 into a genetically T cell-deficient Dahl salt-sensitive (SS) rat model. The results demonstrated that reactive oxygen species produced by NADPH oxidase 2 in T cells participate in the amplification of SS hypertension and associated renal damage and identifies a potential mechanism that exacerbates the salt-sensitive phenotype.


  • Open Access

    Dietary Protein, Chronic Salt-Sensitive Hypertension, and Kidney Damage

    by David L. Mattson, John Henry Dasinger, Justine M. Abais-Battad

    It has been estimated that over a fifth of deaths worldwide can be attributed to dietary risk factors. A particularly serious condition is salt-sensitive (SS) hypertension and renal damage, participants of which demonstrate increased morbidity and mortality. Notably, a large amount of evidence from humans and animals has demonstrated that other components of the diet can also modulate hypertension and associated end-organ damage. Evidence presented in this review provides support for the view that immunity and inflammation serve to amplify the development of SS hypertension and leads to malignant disease accompanied by tissue damage. Interestingly, SS hypertension is modulated by changes in dietary protein intake, which also influences immune mechanisms. Together, the evidence presented in this review from animal and human studies indicates that changes in dietary protein source have profound effects on the gut microbiota, microbiota-derived metabolites, gene expression, immune cell activation, the production of cytokines and other factors, and the development of SS hypertension and kidney damage.


  • Open Access

    Microbiota-associated mechanisms underlying sexual dimorphism in hypertension

    by John Henry Dasinger, Bina Joe, Justine M Abais-Battad

    Consistent research over the last 20 years has shown that there are clear sex differences in the pathogenesis of hypertension, the leading risk factor for the development of cardiovascular diseases. More recently, there is evidence in both humans and experimental animal models that causally implicates the gut microbiota in hypertension. It therefore follows that sex differences in the gut microbiota may mediate the extent of disease between sexes. This new field is rapidly changing and advancing, and the purpose of this review is to cover the most up-to-date evidence regarding the sexual dimorphism of the gut microbiota and its potential influence on the differential manifestation of hypertension in males versus females. Emphasis will be placed on the mechanisms thought to contribute to these sex differences in both the gut microbiota and hypertension, including sex steroid hormones, gut-derived metabolites, the immune system, and pregnancy.